Reliability and validity of the Sheehan disability scale modified for pathological gambling

被引:30
作者
Hodgins, David C. [1 ]
机构
[1] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada
关键词
Functional Impairment; Pathological Gambling; Sheehan Disability Scale; Clinical Trials; IMPAIRMENT; GAMBLERS;
D O I
10.1186/1471-244X-13-177
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: An interview format version of the Sheehan Disability Scale (SDS) modified to assess gambling treatment outcomes was assessed for reliability and validity. The SDS assesses impairment in work, family and social functioning related to mental disorders. Methods: A pilot study (N = 21) determined the preferred wording for oral administration. Participants with pathological gambling in a relapse prevention clinical trial completed the scale and other validation measures at baseline, six and twelve month follow-ups (N = 169). Results: Confirmatory factor analysis supported a one factor solution and the scale had good internal reliability for a three item scale. The SDS was sensitive to change and correlations with recent gambling behaviour and severity were moderate as expected. Similarly, correlations with self-efficacy, perceived control over gambling, and craving were moderate, but they were lower for less directly related constructs such as depression and perceived family and friend support. Conclusions: The SDS is a brief, psychometrically sound, outcome measure of impairment associated with gambling disorders that can be administered by telephone.
引用
收藏
页数:6
相关论文
共 31 条
[1]  
[Anonymous], 2001, CANADIAN PROBLEM GAM
[2]  
Arbuckle J.L., 2007, Amos
[3]   Extended release carbamazepine in the treatment of pathological gambling: An open-label study [J].
Black, Donald W. ;
Shaw, Martha C. ;
Allen, Jeff .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (05) :1191-1194
[4]   An open-label trial of escitalopram in the treatment of pathological gambling [J].
Black, Donald W. ;
Shaw, Martha ;
Forbush, Kelsie T. ;
Allen, Jeff .
CLINICAL NEUROPHARMACOLOGY, 2007, 30 (04) :206-212
[5]   Bupropion in the treatment of pathological gambling - A randomized, double-blind, placebo-controlled, flexible-dose study [J].
Black, Donald W. ;
Arndt, Stephan ;
Coryell, William H. ;
Argo, Tami ;
Forbush, Kelsie T. ;
Shaw, Martha C. ;
Perry, Paul ;
Allen, Jeff .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (02) :143-150
[6]   Validity of the Problem Gambling Severity Index Interpretive Categories [J].
Currie, Shawn R. ;
Hodgins, David C. ;
Casey, David M. .
JOURNAL OF GAMBLING STUDIES, 2013, 29 (02) :311-327
[7]  
Gerstein DR, 1999, PSYCHIAT RES
[8]   N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: A pilot study [J].
Grant, Jon E. ;
Kim, Suck Won ;
Odlaug, Brian L. .
BIOLOGICAL PSYCHIATRY, 2007, 62 (06) :652-657
[9]  
Hodgins D.C., 2004, INT GAMBL STUD, V4, P99
[10]  
Hodgins D. C., 2008, GUIDE ASSESSMENTS WO, P370